Belgium· BE-AMP-SAM300045-00
Furosemide Fresenius Kabi 20 mg/2 ml
A furosemide product containing furosemide, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 19 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Furosemide is registered in 19 of 19 countries.
Countries holding a registration under ATC C03CA01 (furosemide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Furosemide · ATC C03CA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of furosemide costs, country by country.
Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.029 in United States to $0.25 in Switzerland — a ×8.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Furosemide · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.25
- IT Italy$0.072
- FR France$0.070
- US United States$0.029 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Furosemide
- Manufacturer
- Fresenius Kabi
- Country
- Belgium (BE)
- ATC code
- C03CA01
- ATC class
- Furosemide
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2450112
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
424 interactions on record for furosemide.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Furosemide · interactions on record
424 records
- 15 severe
- 191 moderate
- 13 minor
- 203 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Furosemide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFurosemideNorthStar Rx LLC
- CzechiaFUROSEMID HAMELNhameln pharma gmbh, Hameln
- FinlandFurosemid hamelnHameln Pharma GmbH
- SpainFUROSEMIDA ACCORD 20 MG/2 ML SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandFurosemid AccordAccord Healthcare Polska Sp. z o.o.
- NorwayFurosemid hamelnHameln
- SwedenFurosemid Accord 10 mg/ml Injektions-/infusionsvätska, lösningAccord Healthcare B.V.
- IcelandFurosemide KalceksKalceks AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Furohexal, Furon
- Bulgaria · Furosemide Basi, Фурантрил
- Cyprus · Furosemide Accord, Furosemide Waymade
- Czechia · Furon, Furorese
- Germany · Furanthril, Furo-Ct
- Denmark · Diural, Furix
- Estonia · Furosemide Accord, Furosemide Basi
- Spain · Furosemida Altan, Furosemida Aurovitas
- Finland · Furesis, Furosemid Hameln
- France · Furosemide Accord, Furosemide Arrow
- United Kingdom (Northern Ireland) · Frusol, Furosemide
- Greece · Demefur, Fudesix
- Croatia · Edemid, Edemid Forte
- Hungary · Furon, Furosemid Al
- Ireland · Furosemide, Furosemide Accord Healthcare Ireland
- Iceland · Furix, Furosemide Kalceks
- Italy · Furosemide Aurobindo, Furosemide Aurobindo Italia
- Lithuania · Furosemid Polpharma, Furosemide Accord
- Luxembourg · Furosemid Ratiopharm, Furosemide Eg
- Latvia · Furosemide Basi, Furosemide Kalceks
- Malta · Furosemide Accord Healthcare, Furosemide Clonmel
- Netherlands · Furosemide Accord, Furosemide Auro
- Norway · Diural, Furix
- Poland · Furosemid Accord, Furosemid Hameln
- Portugal · Entix, Frunov
- Romania · Furosemid Arena, Furosemid Basi
- Sweden · Furix, Furosemid Accord
- Slovenia · Edemid, Furosemid Hameln
- Slovakia · Furon, Furorese
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2275dcaa-f6b4-49ee-9002-889a4473b3ee GET /v1/drugs/2275dcaa-f6b4-49ee-9002-889a4473b3ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Furosemide Fresenius Kabi 20 mg/2 ml",
"name_fr": "Furosemide Fresenius Kabi 20 mg/2 ml",
"name_nl": "Furosemide Fresenius Kabi 20 mg/2 ml",
"amp_code": "SAM300045-00",
"strengths": [
"20.0000",
"20.0000",
"15.0000",
"2.5600"
],
"pack_count": 3,
"substances": [
"Furosemide",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Furosemide",
"authorisation_numbers": [
"BE300045"
]
}See everything about furosemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.